Deng, Z., Li, L., Meng, Z., Zeng, G., Cao, R., & Liu, R. Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer. BMC.
Chicago Style (17th ed.) CitationDeng, Zhaoda, Lincheng Li, Zihe Meng, Guineng Zeng, Rui Cao, and Rong Liu. Pan-cancer Analysis Shows That TNFSF4 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Liver Cancer. BMC.
MLA (9th ed.) CitationDeng, Zhaoda, et al. Pan-cancer Analysis Shows That TNFSF4 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Liver Cancer. BMC.
Warning: These citations may not always be 100% accurate.